Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Tadalafil and Influenza Vaccine in Abdominal Cancer
NCT02998736Phase 1Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Nov 2017
- Primary completion
- Sep 2022
- Modality
- Small Molecules, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label trial of tadalafil and influenza vaccine in Abdominal cancer (2 arms), sponsored by Ottawa Hospital Research Institute. Primary endpoints: Regimen Limiting Toxicities at Day 35 and CTCAE Adverse Events at Day 35. Started Nov 2017; status: completed.
02
Drugs
tadalafilinfluenza vaccine
03
Conditions
Abdominal cancer
Beyond the preview
Go deeper on NCT02998736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02998736.